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doi:10.1016/j.ejvs.2011.07.022Abstract Objectives: Dialysis-dependent patients often have central venous drainage
complications. In patients with functioning arm arteriovenous fistula, this may result in venous
hypertension, arm oedema and vascular access failure. Percutaneous angioplasty and stent
implantation might be inadequate to resolve these issues. In these cases, new access can
potentially be created with anastomosis to the subclavian vein, iliac vein or vena cava or by
making a veno-venous graft to bypass the thrombosis.
The aim of this study was to assess the utility of unusual bypasses in vascular access in
patients with the central vein thrombosis.
Materials: A total of 49 patients were treated. The mean number of previous vascular access
surgery procedures was 7.6 (3e17). We performed 19 axilloeiliac, 14 axilloeaxillary bypasses
and 16 conduits from the arm fistula to the jugular (nine conduits) or subclavian (seven
conduits) vein for haemodialysis purposes.
Results: All fistulas except one were used for haemodialysis. One patient died before the first
use of the fistula. At 12 months, the primary, primary assisted and secondary patency rates
were 85.4%, 89.6% and 95.8%, respectively. The follow-up period ranged from 1 to 84 months.
Conclusion: Unusual grafts are an efficient option as a permanent vascular access for haemo-
dialysis purposes in patients with central vein occlusion.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Many years ago, vascular access was called the “Achilles
heel of dialysis.”1 Because medical care of dialysed
patients has improved and the duration of dialysis is
generally prolonged, maintaining long-term vascular access2 599 24 67; fax: þ48 22 599
(T. Jakimowicz).
ty for Vascular Surgery. Publishehas become even more difficult. According to most
recommendations, we should always assess the patient for
peritoneal dialysis; if this is not possible, the aim is to
perform an arteriovenous fistula (AVF) using the native
vessels and to place it distally on the upper extremity.2
However, problems remain when ensuring good vascular
access in patients with many previous AVF failures. In this
group, it is necessary, usually between the previous fistula
thrombosis and the maturation of a new one, to insertd by Elsevier Ltd. All rights reserved.
Table 1 Patient data, ordered by the location of the venous obstruction. (BB: bilateral brachiocephalic; UB: unilateral
brachiocephalic; DS: distal subclavian; PS: proximal subclavian; AI: axillo-iliac AVF; NG: necklace graft; BS: veno-venous bypass


















1. BB no 3 40 AI graft thrombosis thrombectomy
2. BB no 5 55 AI
3. BB no 6 58 AI graft infection graft removal and contralateral
groin permanent catheter placement
4. BB no 6 39 AI
5. BB no 6 55 AI
6. BB no 7 59 AI died due to pneumonia
7. BB no 8 39 AI
8. BB no 8 45 AI graft thrombosis thrombectomy
9. BB no 9 47 AI stenosis of the
venous anastomosis
new venous anastomosis to IVC
10. BB no 9 78 AI
11. BB no 9 42 AI graft thrombosis thrombectomy
12. BB no 9 83 AI graft thrombosis thrombectomy
13. BB no 11 37 AI
14. BB no 11 54 AI
15. BB no 12 38 AI
16. BB no 12 43 AI stenosis of the
venous anastomosis
venous anastomosis angioplasty
17. BB no 12 84 AI
18. BB no 14 38 AI graft thrombosis thrombectomy
19. BB no 14 68 AI
20. UB no 3 48 NG graft infection graft removal and groin permanent
catheter placement
21. UB no 4 34 NG
22. UB no 4 53 NG graft thrombosis thrombectomy
23. UB no 4 38 NG
24. UB no 5 25 NG
25. UB no 5 58 NG
26. UB no 5 87 NG
27. UB no 6 42 NG
28. UB no 7 38 NG
29. UB no 8 45 NG
30. UB no 8 44 NG graft thrombosis thrombectomy
31. UB no 9 41 NG graft thrombosis thrombectomy
32. UB no 10 48 NG stenosis of the
venous anastomosis
venous anastomosis angioplasty
33. UB no 17 56 NG graft thrombosis thrombectomy
34. DS yes 5 51 BS stenosis of the
venous anastomosis
venous anastomosis angioplasty
35. DS yes 6 49 BS
36. DS yes 6 34 BS
37. DS yes 6 39 BS graft thrombosis thrombectomy
38. DS yes 6 47 BS
39. DS yes 7 33 BS
40. DS yes 9 43 BS
41. PS yes 4 33 BJ graft thrombosis thrombectomy
42. PS yes 5 31 BJ graft thrombosis thrombectomy
43. PS yes 5 64 BJ
44. PS yes 6 72 BJ
45. PS yes 7 72 BJ
46. PS yes 8 63 BJ
47. PS yes 8 41 BJ
(continued on next page)
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48. PS yes 9 40 BJ
49. PS yes 10 61 BJ
Figure 1 Venography of AVF showing an occluded subclavian
vein with the collateral vessels.
844 T. Jakimowicz et al.a temporary central catheter into the subclavian or jugular
vein.3 This can result in stenosis or thrombosis of either or
both the subclavian and brachiocephalic veins. In this case,
if we attempt to perform AVF, arm oedema (due to the
venous hypertension), insufficient haemodialysis and, ulti-
mately, access failure will result. The best solution for this
problem is to perform percutaneous transluminal angio-
plasty and stent implantation in the stenosed vessels.4
However, when the vein is occluded, endovascular tech-
niques could be insufficient. In those cases, new access can
potentially be created with anastomosis to the proximal
subclavian or iliac vein, superior or inferior vena cava or byFigure 2 PTFE bypass of the thrombosed distal subclavian
vein with a spared native vessel fistula (7 patients).making a veno-venous graft to bypass the thrombosis.
There have also been case reports of venous anastomoses
of AVFs to popliteal or renal veins or even to the left
ventricle.5e7
The aim of this study was to assess the utility of unusual
bypasses in the vascular access for haemodialysis in
patients with the central vein thrombosis.
Materials and Methods
Our department is a reference vascular access centre with
the annual number of AVFs created approaching 500. All
patient data (operative and follow-up) are collected in
a prospectively maintained database. From this database,
we retrospectively found 49 dialysed patients with treat-
ment of a central venous occlusion, between 1990 and
2009. The mean age was 43 years (28e72 years), the mean
duration of haemodialysis was 4.2 years and the mean
number of the previous vascular access surgery procedures
was 7.6 (3e17). According to Sidawy,8 the risk factors of
access failure were: diabetes in 23 and hypertension in 47
patients. All had occlusions of at least one central vein: 19
had bilateral obstruction of the brachiocephalic vein, 16
had unilateral occlusion of various parts of the subclavianFigure 3 PTFE bypass of the thrombosed proximal subclavian
vein with spared native vessel fistula (9 patients).
Figure 5 Venography showing bilateral brachiocephalic vein
thrombosis.
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vein. In all cases, the reason for obstruction was previous
catheterisation of the vein in 40 jugular and in 28 subcla-
vian veins (the sum is the total number of the occluded
veins). The vascular status was confirmed by angio-
computed tomography (angio-CT) or venography. The
detailed patient data are presented in Table 1.
The vascular access policy in our department is to
perform native vessel AVF and to maintain its patency as
long as possible. Therefore, in 16 patients with a func-
tioning arm fistula and oedema caused by the occluded
subclavian vein (Fig. 1), we corrected the outflow and
bypassed the occluded vessel with the externally sup-
ported polytetrafluoroethylene (PTFE) graft anastomosed
to the subclavian (seven patients) or the jugular (nine
patients) vein, as shown in Figs. 2 and 3. Therefore, it was
possible to exploit the fistula immediately after surgical
reconstruction and to avoid the need for placement of
a new catheter.
To create a new vascular access in 14 patients with
a unilateral occlusion of the brachiocephalic vein and co-
existing contralateral occlusion of the subclavian vein, it
was necessary to perform a PTFE bridge between the
subclavian artery and the contralateral subclavian vein
(prosthetic axillaryeaxillary chest access: necklace graft),
which is shown in Fig. 4.
The remaining 19 patients had a bilateral obstruction of
the brachiocephalic veins (Fig. 5). In those cases, we made
a subcutaneous PTFE conduit from the subclavian artery to
the external iliac vein (prosthetic axillary/femoral body
wall access) (Fig. 6) with the retroperitoneal approach to
the external iliac vein.
In all cases, we used a 5- or 6-mm externally supported
PTFE graft. Anticoagulants (low molecular weight heparin,Figure 6 Subcutaneous PTFE conduit from the subclavian
artery to the external iliac vein (prosthetic axillary-femoral
body wall access 19 patients).
Figure 4 Necklace graft e subcutaneous PTFE bridge from
the subclavian artery to the contralateral subclavian vein (14
patients).
846 T. Jakimowicz et al.LMWH) were administered only in the 10 patients with
axilloeiliac conduits. The vascular anastomoses were per-
formed as described elsewhere.9
The primary method of AVF assessment was its effec-
tiveness for haemodialysis, which was measured with the
Kt/V index10 and calculated at least monthly. A value of
<1.2 was an indication for Doppler ultrasound or angio-CT
scan. Other indications for vascular diagnostics were
blood flow during dialysis <200 ml/min or venous pressure
higher than 100 mmHg.
Statistical analysis was performed with STATISTICA (data
analysis software system), StatSoft, Inc. (2010), version
9.1. (www.statsoft.com). Primary, primary assisted and
secondary patency rates with standard errors were calcu-
lated with KaplaneMaier survival estimates in accordance
with the Society for Vascular Surgery and the American
Association for Vascular Surgery recommendations for AV
haemodialysis access.8
Results
All grafts except one were used for haemodialysis. One
patient died with a good function of the newly created
vascular access before its initial usage (24 days after
surgery caused by severe pneumonia). The follow-up periodFigure 7 Graft extension with the anastomosis to the infe-
rior vena cava.ranged from 1 to 84 months (mean 38 months). In the
Doppler ultrasound and angio-CT scans, we found signifi-
cant stenosis of the venous anastomosis in four cases (8, 12,
14 and 16 months postoperatively), three of which were
successfully treated by angioplasty. The remaining patient
required graft extension with the anastomosis to the infe-
rior vena cava (Fig. 7).
During the follow-up period, 12 patients required graft
thrombectomy: once in seven patients, two times in
three and three times in two patients. Five of the throm-
bectomies were unsuccessful. One axilloeiliac and one
axilloe-axillary bypass were removed 14 and 22 months
after the surgery as a result of infection. The primary,
primary assisted and secondary patency rates with number
at risk and standard errors for yearly intervals are shown in
Figs. 8e10, respectively.
All patients with lost vascular access were converted to
permanent femoral venous catheters. No patient suffered
fromhand ischaemia as a result of subclavian steal syndrome.Discussion
Puncturing of the central vein and dialysis catheter place-
ment is the only remaining option in patients with acute
renal failure and also in cases when vascular access fails.
However, it can cause central vein thrombosis, thereby
making vascular access problematic.11,12 For that reason,
the indication is to cannulate the jugular prior to the
subclavian vein. However, in our series, we observed 28
occlusions as a consequence of subclavian vein catheters.
Those patients were referred from other hospitals, and we
had no influence on the site of puncture. Nowadays, there
is a trend always to propose peritoneal dialysis (PD) as the
first choice even in acute cases but our study period is 20
years and during that time, PD was unpopular in Poland;
therefore, only four patients had a documented history of
PD. Now we propose PD to every patient referred with
difficult vascular access problem.
In cases of post-catheter venous stenosis, angioplasty,
usually with a venous stent placement, is the treatment of
choice and frequently alleviates the problem. Some authors
also propose its use for the obstructed vein.4 As the study
period is 20 years, in the beginning, endovascular treat-
ment of venous obstruction was not that common. Nowa-
days, our policy is to attempt venous angioplasty, usually
with stent placement in vascular access outflow problems
whenever possible. We have also a limited experience in
endovascular treatment of venous occlusion but it affects
only the past few years. However, the dilemma remains in
the case when endovascular treatment is not possible,
especially in patients with a functioning AVF and arm
oedema as a result of thrombosis of the subclavian or bra-
chiocephalic vein. The simplest treatment is to ligate the
fistula, after which the arm oedema usually promptly
resolves. However, this way, vascular access is lost. When
such cases are presented to our department, after 1989
when the procedure was first described by Campistol,13 we
have attempted to improve the outflow by bypassing the
occluded vein. When occlusion is in the distal part of the
subclavian vein and the proximal part is not blocked,
a veno-venous graft is performed by connecting the
Figure 8 KaplaneMeier curve for primary patency rate with standard error bars. Standard error exceeded 10% after 54 months.
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vian vein (Fig. 2). If the proximal part of the subclavian vein
is not available, a graft from the AVF to the jugular vein is
carried out (Fig. 3). The most important advantage of this
procedure is that the existing arm fistula can be used
immediately after the vascular reconstruction; hence,
there is no need for vein maturation, and the patient is not
exposed to the necessity of catheter placement and
potential stenosis or thrombosis of another vein. In patients
with newly created vascular access (necklace or body wallFigure 9 KaplaneMeier curve for primary assisted patency rate w
months.grafts), we must place the catheter in the femoral vein and
wait 5 weeks before the first needling.
It is also possible to perform a veno-venous graft from
the functioning AVF to the contralateral subclavian or
jugular vein,14 when there is lack of patent ipsilateral
veins; however, we did not have any patient with this
indication.
When there is a need to create a new AVF, such as in
cases of unilateral occlusion of the brachiocephalic vein
and co-existing contralateral occlusion of the subclavianith standard error bars. Standard error exceeded 10% after 54
Figure 10 KaplaneMeier curve for secondary patency rate with standard error bars. Standard error for secondary patency did not
reach 10%.
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of the arm fistula, we prefer a prosthetic axillaryeaxillary
chest access (necklace graft, as shown in Fig. 4). This has
previously been described as a good method for vascular
access in selected cases.15e17 Jean-Baptiste et al. have
described a slightly different technique, performing
a prosthetic loop on the anterior chest wall;18 however, we
find it more difficult and inconvenient to use. There is also
a series describing inter-arterial chest loops.19,20 We did
not perform such operations because, in our opinion, they
are associated with the increased risk of hand ischaemia.
The most complex patients requiring vascular access are
those with bilateral brachiocephalic vein occlusion. In such
circumstances, there is no possibility to create vascular
access on the upper part of the body. Therefore, the first
choice for AVF is saphenous and second is a PTFE loop on
the thigh21 or a superficial femoral vein transposition.22
Nevertheless, the patients usually have a long vascular
access history and often do not have a saphenous or any
groin veins available, usually due to the frequent groin
dialysis catheter placement. In 1987, Cimochowski et al.
have reported a series of such patients that underwent
axillary artery-to-iliac vein grafts.23 This method was also
used in our cohort, and we have found it very valuable for
those desperate patients.
The above-described ‘out of the ordinary’ PTFE grafts
are an efficient option for performing AVF or prolonging the
usefulness of existing vascular access for haemodialysis
purposes in patients with the central vein occlusion.Conflict of Interest/Funding
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